Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Onychomycosis (Tinea Unguium) Drug Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Onychomycosis (Tinea Unguium) Drug Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Onychomycosis (Tinea Unguium) Drug Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Onychomycosis (Tinea Unguium) Drug Market-Segmentation by Type 5.1 External 5.2 Oral 6 Global Onychomycosis (Tinea Unguium) Drug Market-Segmentation by Application 6.1 Age above 50 6.2 Age 18-50 6.3 Age under 18 7 Global Onychomycosis (Tinea Unguium) Drug Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Xiuzheng Pharmaceutical 8.1.1 Xiuzheng Pharmaceutical Profile 8.1.2 Xiuzheng Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Xiuzheng Pharmaceutical Product/Solution Launches and Enhancements Analysis 8.1.4 Xiuzheng Pharmaceutical Business Overview/Recent Development/Acquisitions 8.2 Kaken Pharmaceutical 8.2.1 Kaken Pharmaceutical Profile 8.2.2 Kaken Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Kaken Pharmaceutical Product/Solution Launches and Enhancements Analysis 8.2.4 Kaken Pharmaceutical Business Overview/Recent Development/Acquisitions 8.3 Valeant Pharma 8.3.1 Valeant Pharma Profile 8.3.2 Valeant Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Valeant Pharma Product/Solution Launches and Enhancements Analysis 8.3.4 Valeant Pharma Business Overview/Recent Development/Acquisitions 8.4 Qilu Pharmaceutical 8.4.1 Qilu Pharmaceutical Profile 8.4.2 Qilu Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Qilu Pharmaceutical Product/Solution Launches and Enhancements Analysis 8.4.4 Qilu Pharmaceutical Business Overview/Recent Development/Acquisitions 8.5 GSK 8.5.1 GSK Profile 8.5.2 GSK Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 GSK Product/Solution Launches and Enhancements Analysis 8.5.4 GSK Business Overview/Recent Development/Acquisitions 8.6 Pfizer 8.6.1 Pfizer Profile 8.6.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Pfizer Product/Solution Launches and Enhancements Analysis 8.6.4 Pfizer Business Overview/Recent Development/Acquisitions 8.7 Novartis 8.7.1 Novartis Profile 8.7.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 Novartis Product/Solution Launches and Enhancements Analysis 8.7.4 Novartis Business Overview/Recent Development/Acquisitions 8.8 Johnson & Johnson 8.8.1 Johnson & Johnson Profile 8.8.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis 8.8.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions 8.9 Letai 8.9.1 Letai Profile 8.9.2 Letai Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Letai Product/Solution Launches and Enhancements Analysis 8.9.4 Letai Business Overview/Recent Development/Acquisitions 8.10 Galderma 8.10.1 Galderma Profile 8.10.2 Galderma Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Galderma Product/Solution Launches and Enhancements Analysis 8.10.4 Galderma Business Overview/Recent Development/Acquisitions 9 Global Onychomycosis (Tinea Unguium) Drug Market-Segmentation by Geography 10 North America 10.1 North America Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Onychomycosis (Tinea Unguium) Drug Production Analysis from 2014-2019E 10.4 North America Onychomycosis (Tinea Unguium) Drug Consumption Analysis from 2014-2019E 10.5 North America Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E 10.6 North America Onychomycosis (Tinea Unguium) Drug Value, Production and Market Share by Type (2014-2019E) 10.7 North America Onychomycosis (Tinea Unguium) Drug Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Onychomycosis (Tinea Unguium) Drug by Country (United States, Canada) 10.8.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2014-2019E) 10.8.2 North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2014-2019E) 10.9 North America Onychomycosis (Tinea Unguium) Drug Market PEST Analysis 11 Europe 11.1 Europe Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Onychomycosis (Tinea Unguium) Drug Production Analysis from 2014-2019E 11.4 Europe Onychomycosis (Tinea Unguium) Drug Consumption Analysis from 2014-2019E 11.5 Europe Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E 11.6 Europe Onychomycosis (Tinea Unguium) Drug Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Onychomycosis (Tinea Unguium) Drug Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Onychomycosis (Tinea Unguium) Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2014-2019E) 11.8.2 Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2014-2019E) 11.9 Europe Onychomycosis (Tinea Unguium) Drug Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Production Analysis from 2014-2019E 12.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E 12.6 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Onychomycosis (Tinea Unguium) Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market PEST Analysis 13 Latin America 13.1 Latin America Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Onychomycosis (Tinea Unguium) Drug Production Analysis from 2014-2019E 13.4 Latin America Onychomycosis (Tinea Unguium) Drug Consumption Analysis from 2014-2019E 13.5 Latin America Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E 13.6 Latin America Onychomycosis (Tinea Unguium) Drug Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Onychomycosis (Tinea Unguium) Drug Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Onychomycosis (Tinea Unguium) Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Country (2014-2019E) 13.8.2 Latin America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2014-2019E) 13.9 Latin America Onychomycosis (Tinea Unguium) Drug Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Production Analysis from 2014-2019E 14.4 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E 14.6 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Onychomycosis (Tinea Unguium) Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market PEST Analysis 15 Future Forecast of the Global Onychomycosis (Tinea Unguium) Drug Market from 2018-2026 15.1 Future Forecast of the Global Onychomycosis (Tinea Unguium) Drug Market from 2019-2026 Segment by Region 15.2 Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Onychomycosis (Tinea Unguium) Drug Market Value ($) and Growth Rate of Onychomycosis (Tinea Unguium) Drug from 2014-2026 Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Segment by Product Type from 2014-2026F Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Segment by Application from 2014-2019E Figure Onychomycosis (Tinea Unguium) Drug Picture Table Product Specifications of Onychomycosis (Tinea Unguium) Drug Table Driving Factors for this Market Table Industry News of Onychomycosis (Tinea Unguium) Drug Market Figure Value Chain Status of Onychomycosis (Tinea Unguium) Drug Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Onychomycosis (Tinea Unguium) Drug Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure External of Onychomycosis (Tinea Unguium) Drug Figure Oral of Onychomycosis (Tinea Unguium) Drug Table Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Onychomycosis (Tinea Unguium) Drug Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Age above 50 of Onychomycosis (Tinea Unguium) Drug Figure Age 18-50 of Onychomycosis (Tinea Unguium) Drug Figure Age under 18 of Onychomycosis (Tinea Unguium) Drug Table Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Onychomycosis (Tinea Unguium) Drug Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Onychomycosis (Tinea Unguium) Drug Figure Online Channel of Onychomycosis (Tinea Unguium) Drug Table Xiuzheng Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region) Figure Xiuzheng Pharmaceutical Sales and Growth Rate from 2014-2019E Figure Xiuzheng Pharmaceutical Revenue ($) and Global Market Share from 2014-2019E Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Kaken Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region) Figure Kaken Pharmaceutical Sales and Growth Rate from 2014-2019E Figure Kaken Pharmaceutical Revenue ($) and Global Market Share from 2014-2019E Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Valeant Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure Valeant Pharma Sales and Growth Rate from 2014-2019E Figure Valeant Pharma Revenue ($) and Global Market Share from 2014-2019E Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Qilu Pharmaceutical Profile (Company Name, Plants Distribution, Sales Region) Figure Qilu Pharmaceutical Sales and Growth Rate from 2014-2019E Figure Qilu Pharmaceutical Revenue ($) and Global Market Share from 2014-2019E Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table GSK Profile (Company Name, Plants Distribution, Sales Region) Figure GSK Sales and Growth Rate from 2014-2019E Figure GSK Revenue ($) and Global Market Share from 2014-2019E Table GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Pfizer Profile (Company Name, Plants Distribution, Sales Region) Figure Pfizer Sales and Growth Rate from 2014-2019E Figure Pfizer Revenue ($) and Global Market Share from 2014-2019E Table Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novartis Profile (Company Name, Plants Distribution, Sales Region) Figure Novartis Sales and Growth Rate from 2014-2019E Figure Novartis Revenue ($) and Global Market Share from 2014-2019E Table Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region) Figure Johnson & Johnson Sales and Growth Rate from 2014-2019E Figure Johnson & Johnson Revenue ($) and Global Market Share from 2014-2019E Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Letai Profile (Company Name, Plants Distribution, Sales Region) Figure Letai Sales and Growth Rate from 2014-2019E Figure Letai Revenue ($) and Global Market Share from 2014-2019E Table Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Galderma Profile (Company Name, Plants Distribution, Sales Region) Figure Galderma Sales and Growth Rate from 2014-2019E Figure Galderma Revenue ($) and Global Market Share from 2014-2019E Table Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Onychomycosis (Tinea Unguium) Drug Production Value ($) by Region from 2014-2019E Table Global Onychomycosis (Tinea Unguium) Drug Production Value Share by Region from 2014-2019E Table Global Onychomycosis (Tinea Unguium) Drug Production by Region from 2014-2019E Table Global Onychomycosis (Tinea Unguium) Drug Consumption Value ($) by Region from 2014-2019E Table Global Onychomycosis (Tinea Unguium) Drug Consumption by Region from 2014-2019E Table North America Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E Table North America Onychomycosis (Tinea Unguium) Drug Value ($) by Type (2014-2019E) Table North America Onychomycosis (Tinea Unguium) Drug Production by Type (2014-2019E) Table North America Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019E) Table North America Onychomycosis (Tinea Unguium) Drug Consumption by Country (2014-2019E) Table North America Onychomycosis (Tinea Unguium) Drug Consumption Value ($) by Country (2014-2019E) Figure North America Onychomycosis (Tinea Unguium) Drug Market PEST Analysis Table Europe Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E Table Europe Onychomycosis (Tinea Unguium) Drug Value ($) by Type (2014-2019E) Table Europe Onychomycosis (Tinea Unguium) Drug Production by Type (2014-2019E) Table Europe Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019E) Table Europe Onychomycosis (Tinea Unguium) Drug Consumption by Country (2014-2019E) Table Europe Onychomycosis (Tinea Unguium) Drug Consumption Value ($) by Country (2014-2019E) Figure Europe Onychomycosis (Tinea Unguium) Drug Market PEST Analysis Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Value ($) by Type (2014-2019E) Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Production by Type (2014-2019E) Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019E) Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption by Country (2014-2019E) Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market PEST Analysis Table Latin America Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E Table Latin America Onychomycosis (Tinea Unguium) Drug Value ($) by Type (2014-2019E) Table Latin America Onychomycosis (Tinea Unguium) Drug Production by Type (2014-2019E) Table Latin America Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019E) Table Latin America Onychomycosis (Tinea Unguium) Drug Consumption by Country (2014-2019E) Table Latin America Onychomycosis (Tinea Unguium) Drug Consumption Value ($) by Country (2014-2019E) Figure Latin America Onychomycosis (Tinea Unguium) Drug Market PEST Analysis Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Import and Export from 2014-2019E Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value ($) by Type (2014-2019E) Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Production by Type (2014-2019E) Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption by Application (2014-2019E) Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption by Country (2014-2019E) Table Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market PEST Analysis Table Global Onychomycosis (Tinea Unguium) Drug Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Forecast by Region (2019-2026) Table Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Onychomycosis (Tinea Unguium) Drug Production and Growth Rate Forecast by Type (2019-2026) Table Global Onychomycosis (Tinea Unguium) Drug Consumption and Growth Rate Forecast by Application (2019-2026)